MassMutual Private Wealth & Trust
RYTM icon

MassMutual Private Wealth & Trust’s Rhythm Pharmaceuticals RYTM Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$95 Hold
1
– – ﹤0.01% 2346
2026
Q2 		$111 Buy
+1
New +$90 ﹤0.01% 2382

Other funds holding RYTM

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $109B AUM 51.53% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

MassMutual Private Wealth & Trust's RYTM Position: Q3 2026 in Review

MassMutual Private Wealth & Trust held its Rhythm Pharmaceuticals (RYTM) position steady in Q3 2026 at 1 share worth $95. The position accounts for ﹤0.01% of the portfolio, ranked #2346.

MassMutual Private Wealth & Trust first reported a position in RYTM in Q2 2026 and has held it in 2 quarters since. The position peaked at $111 in Q2 2026. 145 funds tracked by Wall St. Rank hold RYTM as of Q3 2026.

  • MassMutual Private Wealth & Trust held 1 share of Rhythm Pharmaceuticals worth $95 as of Q3 2026.
  • MassMutual Private Wealth & Trust left its Rhythm Pharmaceuticals share count unchanged in Q3 2026.
  • Rhythm Pharmaceuticals made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q3 2026, its #2346 holding.
  • MassMutual Private Wealth & Trust first reported a position in Rhythm Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
  • MassMutual Private Wealth & Trust's Rhythm Pharmaceuticals position peaked at $111 in Q2 2026.
  • 145 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q3 2026, filed 5 Oct 2026.